Biomerica (BMRA) Change in Accured Expenses (2010 - 2026)

Biomerica has disclosed Change in Accured Expenses across 17 years of filings, most recently posting -$117000.0 for Q1 2026.

• Change in Accured Expenses for Q1 2026 came in at -$117000.0, down 1163.64% year-over-year; the trailing twelve-month figure through Feb 2026 was -$3000.0 (down 101.42% YoY), and the FY2025 annual result was $1000.0, down 99.59% from the prior year.
• Change in Accured Expenses came in at -$117000.0 for Q1 2026 at Biomerica, down from $60000.0 in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $1.0 million in Q1 2022 to a low of -$1.6 million in Q2 2022.
• The 5-year median for Change in Accured Expenses is $11000.0 (2025), against an average of -$28725.1.
• Across the five-year window, Change in Accured Expenses plunged 7552.0% in 2022 and surged 7000.0% in 2023, its largest moves.
• Biomerica's Change in Accured Expenses stood at -$1000.0 in 2022, then soared by 7000.0% to $69000.0 in 2023, then tumbled by 107.25% to -$5000.0 in 2024, then soared by 1300.0% to $60000.0 in 2025, then slumped by 295.0% to -$117000.0 in 2026.
• The last three Change in Accured Expenses figures came in at -$117000.0 (Q1 2026), $60000.0 (Q4 2025), and $10000.0 (Q3 2025), per Business Quant data.